Showing 1901 - 1910 of 2252 results

Showing Results for: “type 1 diabetes”

American Diabetes Association Releases Study on Access Barriers to Continuous Glucose Monitors at Cost of Care Summit

Last week, at its first-ever Cost of Care Summit, the American Diabetes Association ® (ADA) shared the results of a new study on Health Equity and Diabetes Technology: A Study of Access to Continuous Glucose Monitors by Payer and Race . The study, featuring analysis by Health Management Associates, finds that although access to CGMs provides potentially life-changing benefits for diabetes management, poorer, older, and Black Americans have less access to these devices than others. “It is disappointing to see that, today, access to vital diabetes management technology like CGMs is uneven and

American Diabetes Association Focuses on Health Disparities Deepened by Pandemic During 81st Scientific Sessions

Leading diabetes researchers and clinicians from around the world highlight impact of health disparities on diabetes care The American Diabetes Association® (ADA) is highlighting the latest understanding of how to address health disparities laid bare by the pandemic at the virtual 81st Scientific Sessions. Taking place June 25–29, the ADA’s Scientific Sessions is the world’s largest scientific meeting focused on diabetes research, prevention, and care. These expert discussions come at a time when 76% of Americans currently living in poverty are people of color. Diabetes prevalence is inversely

Leading Diabetes Organizations Publish Joint Consensus Report on Benefits, Challenges, and Recommendations for Automated Insulin Delivery

A new consensus report addressing the benefits, challenges, and recommendations related to automated insulin delivery (AID) is being jointly published today by two leading diabetes organizations: the American Diabetes Association ® (ADA) and the European Association for the Study of Diabetes (EASD). The ADA and the EASD convened a joint Diabetes Technology Working Group to review the current landscape of AID systems and recommend targeted actions. “The report addresses the clinical usage of AID systems from a practical point of view rather than as a meta-analysis or a review of all relevant

New Research Funding Opportunities in Youth Onset T2D, Mental & Behavioral Health, and Women’s Health in Diabetes

The American Diabetes Association ® (ADA) has launched new requests for applications (RFAs) for the Fall 2022 Grant Cycle to research and expand the field of knowledge to improve the lives of those living with diabetes. The critical topics for research include supporting the behavioral and mental health of people with diabetes, tackling the epidemic of youth onset type 2 diabetes, and improving the lives of women living with diabetes. Each topic offers multiple award mechanisms including—postdoctoral fellowships, junior faculty development, innovative basic, and innovative clinical or

American Diabetes Association® Applauds Policymakers’ Focus on Addressing High Costs of Insulin for Seven Million Americans

Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement in response to the unprecedented number of Members of Congress who invited people living with diabetes to join them at President Donald J. Trump’s State of the Union address: “Tonight, at least 13 Members of Congress will host their constituents that are living with diabetes, and who represent the seven million Americans dependent on insulin, at the State of the Union address. They will elevate the voices of all people with diabetes and their families, many of whom struggle to

Frank J. Snoek, PhD, Receives American Diabetes Association’s® 2019 Richard R. Rubin Award

Frank J. Snoek, PhD, has been selected to receive the American Diabetes Association's® (ADA's) 2019 Richard R. Rubin Award. This award recognizes a behavioral researcher who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes in diverse populations. Dr. Snoek will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. He will deliver the Richard R. Rubin Award Lecture titled, “ #DiabetesPsychologyMatters ,” on Saturday, June 8. Currently, Dr

Rudolph L. Leibel, MD, Named American Diabetes Association’s® 2019 Albert Renold Award Recipient

The American Diabetes Association® (ADA) will present the 2019 Albert Renold Award to Rudolph L. Leibel, MD. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Leibel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. Dr. Leibel is the Christopher J. Murphy Memorial Professor of Diabetes Research, Professor of Pediatrics and Medicine, Head of the

American Diabetes Association® Announces Eight Recipients of 2019 National Scientific and Health Care Achievement Awards

Top researchers, clinicians and educators will be recognized at the 79th Scientific Sessions for outstanding leadership and work to advance diabetes research, prevention, care and treatment The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s 2019 National Scientific and Health Care Achievement Awards. Individually and collectively, their exemplary leadership, mentorship and many achievements have advanced the field of diabetes care and improved health outcomes for people living with diabetes. “This year’s National Scientific and Health Care Achievement

ADA Releases 2021 Standards of Medical Care in Diabetes Centered on Evolving Evidence, Technology, and Individualized Care

Today, the American Diabetes Association® released the 2021 Standards of Medical Care in Diabetes. The 2021 Standards of Care is now live online in Diabetes Care . Based upon the latest scientific diabetes research and clinical trials, the Standards of Care includes new and updated recommendations and guidelines to care for people with diabetes. The Standards of Medical Care in Diabetes—2021 provides the latest in comprehensive, evidence-based recommendations for the diagnosis and treatment of children and adults with type 1, type 2, or gestational diabetes; strategies for the prevention or

Health Care Organizations Issue Joint Framework to Increase Utilization of Diabetes Self-Management Education and Support

Consensus report outlines the positive impact of diabetes self-management education and support and the critical need for increased access Seven leading diabetes organizations issued a consensus report today highlighting the value of diabetes self-management education and support (DSMES) services as part of comprehensive diabetes medical care. The report provides compelling evidence for the need for increased utilization of DSMES, four key times that DSMES is most beneficial, and specific recommendations for both clinicians and health systems to increase access to and participation in DSMES